Pahor et al [ 18 ] simultaneously published a meta-analysis that suggested a highly significant 26% excess risk of coronary heart disease events with CCB-based therapy compared with other treatments.
1
—
—
Pahor et al [ 18 ] simultaneously published a meta-analysis that suggested a highly significant 26% excess risk of coronary heart disease events with CCB-based therapy compared with other treatments.